KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 60 filers reported holding KINNATE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86,743 | -53.8% | 61,959 | 0.0% | 0.00% | – |
| Q2 2023 | $187,736 | -93.6% | 61,959 | -86.7% | 0.00% | – |
| Q1 2023 | $2,914,881 | -48.4% | 466,381 | -49.7% | 0.00% | – |
| Q4 2022 | $5,650,820 | +1.4% | 926,364 | +98.6% | 0.00% | – |
| Q3 2022 | $5,575,000 | -2.2% | 466,521 | +3.1% | 0.00% | – |
| Q2 2022 | $5,703,000 | +19.7% | 452,278 | +6.9% | 0.00% | – |
| Q1 2022 | $4,765,000 | -30.9% | 423,154 | +8.8% | 0.00% | – |
| Q4 2021 | $6,892,000 | -10.0% | 388,930 | +16.9% | 0.00% | – |
| Q3 2021 | $7,656,000 | +38.7% | 332,575 | +40.3% | 0.00% | – |
| Q2 2021 | $5,520,000 | -3.3% | 237,130 | +29.4% | 0.00% | – |
| Q1 2021 | $5,711,000 | – | 183,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $384,738,000 | 41.79% |
| Foresite Capital Management V, LLC | 875,001 | $34,808,000 | 25.78% |
| Vida Ventures Advisors, LLC | 2,747,074 | $109,279,000 | 22.43% |
| VR Adviser, LLC | 1,473,014 | $58,596,000 | 8.62% |
| RA Capital Management | 3,593,052 | $142,932,000 | 2.00% |
| Logos Global Management LP | 569,602 | $22,659,000 | 1.94% |
| Boxer Capital, LLC | 1,064,665 | $42,352,000 | 1.36% |
| Orbimed Advisors | 3,847,929 | $153,071,000 | 1.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $19,810,000 | 1.07% |
| DAFNA Capital Management LLC | 68,121 | $2,710,000 | 0.81% |